Fusion molecule based on novel TAA variant

• 收藏
• 分享

专利权人:

The Regents of the University of California

发明人:

Zhenhua Li,Arie Belldegrun

申请号：

US15073162

公开号：

US09492520B2

申请日:

2016.03.17

申请国别(地区):

US

年份:

2016

代理人:

摘要：

This invention provides novel carbonic anhydrase (CAIX) nucleic acid and peptide sequences, as well as related methods and compositions, including anti-cancer immunogenic agent(s) (e.g. vaccines and chimeric molecules) that elicit an immune response specifically directed against cancer cells expressing a CAIX antigenic marker. The novel CAIX variant and related compositions are useful in a wide variety of treatment modalities including, but not limited to protein vaccination, DNA vaccination, and adoptive immunotherapy.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/